Skip to content

Brain Network Mechanisms and Biomarkers of Adolescent with Non-Suicidal Self-Injury(NSSI) Regulated by Temporal interference stimulation (TIS)

Brain Network Mechanisms and Biomarkers of Adolescent with Non-Suicidal Self-Injury(NSSI) Regulated by Temporal interference stimulation (TIS)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600121572
Enrollment
Unknown
Registered
2026-04-01
Start date
2026-04-01
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-suicidal self-injury

Interventions

True stimulation group:Temporal interference stimulation
Healthy control group:NA

Sponsors

Zhongda Hospital Southeast university
Lead Sponsor

Eligibility

Sex/Gender
All
Age
12 Years to 18 Years

Inclusion criteria

Inclusion criteria: 1) NSSI group: Participants in the NSSI group were required to meet the following criteria: (1) Fulfillment of the diagnostic criteria for non-suicidal self-injury (NSSI) according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, defined as the presence of non-lethal self-injurious behaviors without explicit suicidal ideation or intent. Typical behaviors included deliberate cutting or stabbing of the skin with sharp objects, burning the skin, or producing multiple wounds on the same body area, particularly at sites that are easily concealed but accessible (e.g., forearms or the anterior thighs). (2) Age between 12 and 18 years. (3) Both the participant and their legal guardian fully understood the study procedures and voluntarily agreed to participate. (4) No use of antipsychotic or antidepressant medications within the past month. (5) No electroconvulsive therapy or other physical treatments, including transcranial magnetic stimulation, within the past six months. (6) Ability to undergo MRI examination. Based on the scores of the UPPS-P Impulsive Behavior Scale, participants were further categorized into high-impulsivity and low-impulsivity subgroups using the mean total score as the cutoff (above and below the mean, respectively). 2) Healthy control group: A demographically matched healthy control group was recruited during the same period. Inclusion criteria were as follows: (1) No subjective complaints of cognitive impairment. (2) Normal neurological examination findings. (3) Normal performance on core cognitive assessments, with depression and anxiety scores within the normal range. (4) Scores on multidimensional neuropsychological assessment scales within the normative range for age and educational level. Similarly, based on UPPS-P total scores (using the mean score as the cutoff), participants were classified into high-impulsivity and low-impulsivity subgroups (above and below the mean, respectively).

Exclusion criteria

Exclusion criteria: Participants were excluded from the study if any of the following conditions were present: 1. History of impaired consciousness. 2. Family history of hereditary diseases. 3. Presence of major neurological or systemic disorders, including central nervous system infections, traumatic brain injury, epilepsy, multiple sclerosis, toxic or metabolic diseases, intracranial tumors, hypothyroidism, diabetes mellitus, or other significant medical conditions. 4. History of major psychiatric disorders, such as schizophrenia, manic episodes, bipolar disorder, or personality changes. 5. Individuals at high risk of suicide, including those with recent or persistent suicidal ideation, suicide plans, previous suicide attempts, or severe mental disorders and psychosocial risk factors related to suicide. 6. Comorbid severe diseases affecting the cardiovascular, hepatic, renal, cerebral, or hematopoietic systems. 7. Contraindications for MRI scanning, including implanted electronic devices or metallic implants. 8. History of electroconvulsive therapy. 9. Evidence of white matter lesions on T2-weighted MRI.

Design outcomes

Primary

MeasureTime frame
Self-harm Frequency and Severity Score;Degree of depression;Cognition;Sleep quality;

Countries

China

Contacts

Public ContactHe Cancan

Southeast University; Zhongda Hospital Southeast university

cche0919@163.com+86 159 0517 2612

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 17, 2026